Cortisone acetate and Thrombocytosis - a phase IV clinical study of FDA data

Summary:

Thrombocytosis is reported as a side effect among people who take Cortisone acetate (cortisone acetate), especially for people who are female, 50-59 old, also take Flexeril, and have Osteoporosis.

The phase IV clinical study analyzes which people have Thrombocytosis when taking Cortisone acetate. It is created by eHealthMe based on reports of 13,905 people who have side effects when taking Cortisone acetate from the FDA, and is updated regularly.

What is Cortisone acetate?

Cortisone acetate has active ingredients of cortisone acetate. It is often used in pain. eHealthMe is studying from 14,098 Cortisone acetate users. Check the latest studies of Cortisone acetate.

What is Thrombocytosis?

Thrombocytosis is found to be associated with 538 drugs and 826 conditions by eHealthMe. Check the latest studies of Thrombocytosis.

On Jul, 19, 2026

13,905 people reported to have side effects when taking Cortisone acetate.
Among them, 14 people (0.1%) have Thrombocytosis.

Could Cortisone acetate cause Thrombocytosis?

Among these 14 people:

What is the gender of people who have Thrombocytosis when taking Cortisone acetate? *

female: 100 %
male: 0.0 %

What is the age of people who have Thrombocytosis when taking Cortisone acetate? *

What are other drugs people take besides Cortisone acetate? *

What are other side effects people have besides Thrombocytosis? *

Platelet Count Increased: 11 people, 78.57%
Wound Infection Staphylococcal: 8 people, 57.14%
Wegener's Granulomatosis (inflammation of the blood vessels lungs sinuses): 8 people, 57.14%
Joint Dislocation (a joint position is changed from normal position): 8 people, 57.14%
Lumbar Spinal Stenosis (a medical condition in which the spinal canal narrows and compresses the spinal cord and nerves at the level of the lumbar bone): 8 people, 57.14%
Lung Disorder (lung disease): 8 people, 57.14%
Malocclusion (a misalignment): 8 people, 57.14%
Metastatic Neoplasm (spreadable cancer tumour): 8 people, 57.14%
Bone Erosion: 8 people, 57.14%
Mouth Ulcers: 8 people, 57.14%

What are the existing conditions these people have? *

Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 8 people, 57.14%
Osteoporosis (bones weak and more likely to break): 8 people, 57.14%
Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 6 people, 42.86%
Thrombocytopenia (decrease of platelets in blood): 4 people, 28.57%

* Approximation only. Some reports may have incomplete information.

Do you take Cortisone acetate and have Thrombocytosis?

- Check whether Thrombocytosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cortisone acetate:

Cortisone acetate (14,098 reports)

Thrombocytosis treatments and more:

Thrombocytosis (5,580 reports)

Browse all side effects of Cortisone acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Thrombocytosis:

Thrombocytosis (538 drugs)

Browse all the conditions that are associated with Thrombocytosis:

Thrombocytosis (826 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cortisone acetate (the active ingredients of Cortisone acetate) and Cortisone acetate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.